Sarajane Ross
127 works · 6,167 citations · h-index 29
Top works
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- Kinetic Analysis of Epidermal Growth Factor Receptor Somatic Mutant Proteins Shows Increased Sensitivity to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Erlotinib
- Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer
- Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.
- Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
- MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
- Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent
- Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1
- Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models
- Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
- Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging
- Identification and immunotherapeutic targeting of antigens induced by chemotherapy
- Hath1, Down-Regulated in Colon Adenocarcinomas, Inhibits Proliferation and Tumorigenesis of Colon Cancer Cells
- Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
- Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5
- The Gli2 Transcription Factor Is Required for Normal Mouse Mammary Gland Development